DULOXETINE AND PROPAFENONE

Duloxetine (a moderate inhibitor of CYP2D6) may inhibit the metabolism of propafenone (a substrate for CYP2D6), increasing the risk of propafenone adverse effects.
The manufacturer advises caution.